Outcomes of patients hospitalized for suspected acute coronary syndrome, in whom the diagnosis was not confirmed: Results from the CZECH-1 and CZECH-2 registries

Lenka Roblová, František Toušek, Petr Toušek, Ladislav Pešl, David Horák, Richard Rokyta, Pavel Červinka, Michael Želízko, Petr Janský, Michael Aschermann, František Holm, Vratislav Pechman, Jiří Jarkovský, Petr Widimský

Cor Vasa 2015, 57(1):e1-e5 | DOI: 10.1016/j.crvasa.2014.11.002  

Background: Suspicion of acute coronary syndrome (ACS) is one of the most common reasons for hospital admission. However, ACS is not confirmed in a high proportion of these patients during hospitalization. Very few details exist about these patients.Aim: To evaluate the clinical characteristics and outcomes of hospitalized patients with a suspicion for ACS that has not been confirmed and compare these results with patients with confirmed ACS.Methods and results: Data were used from the CZECH-1 and CZECH-2 registries, collected in November 2005 and October-November 2012. Both registries contain data from all consecutive patients who have been...

Comparison of hospitalized and ambulatory patients with heart failure in the Czech Republic and Europe. Data from the ESC Heart Failure Long-Term Registry

Jan Krupička, Anna Andrusková, Markéta Hegarová, Marie Lazarová, Filip Málek, Monika Mikolášková, Hana Poloczková, Dagmar Vondráková, Jaromír Hradec

Cor Vasa 2015, 57(1):e6-e11 | DOI: 10.1016/j.crvasa.2014.12.002  

Introduction: The ESC Heart Failure Long-Term Registry (ESC-HFLTR) is a prospective observational study which takes place in 211 cardiology centres of 21 European and Mediterranean countries, members of the European Society of Cardiology.Aim: To compare basic demographic and clinical characteristics of both, the patients hospitalized for acute heart failure and the patients observed in outpatient clinics for chronic heart failure in the Czech Republic with published European-wide data.Methods: Altogether 692 consecutive patients were included in the Czech part of ESC-HFLTR (5.6% of the whole registry) from May 2011 to April 2013. These patients...

Hypertrophic cardiomyopathy and sports

Pavel Gregor

Cor Vasa 2015, 57(1):e12-e15 | DOI: 10.1016/j.crvasa.2014.12.003  

This work summarizes current knowledge and recommendations regarding sports activities of patients with hypertrophic cardiomyopathy. Competitive sports, sports with high intensity level and burst exertion are not recommended. Also performing sports in extremely adverse environmental conditions as hot or cold weather, or high humidity is strongly discouraged; dehydration represents a risk factor as well. Recreational sports are permitted, particularly when individual risk factors and level of outflow tract obstruction are assessed in an individual patient.

Twenty years of alcohol septal ablation document more than a history of a single interventional procedure

Josef Veselka

Cor Vasa 2015, 57(1):e16-e27 | DOI: 10.1016/j.crvasa.2014.12.004  

The first alcohol septal ablation (ASA) was performed in 1994. The concept of "therapeutic acute myocardial infarction" caused by application of concentrated alcohol into coronary artery is not quite unique since certain arrhythmias were treated in a similar way in the past; however, ASA has been discussed widely since its introduction and refused for many years by many cardiologists. Sufficiently robust data from long-term follow-up of patients with hypertrophic obstructive cardiomyopathy treated with ASA were obtained in the past few years only, demonstrating the safety and long-term efficacy of ASA. This article deals with a history of the above-mentioned...

Almanac 2014: cardiomyopathies

Oliver P. Guttmann, Saidi A. Mohiddin, Perry M. Elliott

Cor Vasa 2015, 57(1):e28-e38 | DOI: 10.1016/j.crvasa.2015.01.002  

Cardiomyopathies are myocardial disorders that are not explained by abnormal loading conditions and coronary artery disease. They are classified into a number of morphological and functional phenotypes that can be caused by genetic and non-genetic mechanisms. The dominant themes in papers published in 2012-2013 are similar to those reported in Almanac 2011, namely, the use (and interpretation) of genetic testing, development and application of novel non-invasive imaging techniques and use of serum biomarkers for diagnosis and prognosis. An important innovation since the last Almanac is the development of more sophisticated models for predicting adverse...

Palliative care in cardiology

Martin Gřiva, Martin Loučka, Jiří Šťastný

Cor Vasa 2015, 57(1):e39-e44 | DOI: 10.1016/j.crvasa.2014.12.005  

Palliative care is an approach aimed at improving the quality of life of patients (and their families) faced with a life-threatening condition. Chronic heart failure (CHF) is a progressive disease with increasing incidence and prevalence. Despite (or perhaps, because of) all the advances in medicine, CHF remains one of the leading causes of death. Even with the availability of numerous prognostic tools, an estimate of the course and outcome of a CHF patient continues to pose a challenge. As a result, palliative care should be initiated early and provided in parallel with curative treatment. The cornerstone of palliative care is communication based,...

Early discharge (within 72 h) in low risk patients after acute ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Single centre experience

Kamil Novobílský, Radim Kryza, Petr Černý, Vladimír Kaučák, Jan Mrózek, Ivo Horák

Cor Vasa 2015, 57(1):e45-e49 | DOI: 10.1016/j.crvasa.2014.10.001  

Within past decades the clear trend towards the shortening of the hospital stay in patients with myocardial infarction with ST segment elevations (STEMI) has been observed. The current Guidelines of European Society of Cardiology for the management of acute STEMI state that in the selected patients may be considered early discharge (after approximately 72 h), if adequate follow-up is arranged.Authors present prospective analysis of 25 low risk patients with STEMI, treated with successful primary percutaneous coronary intervention (PCI) and discharged within 48-72 h after admission.Only 1 unplanned hospitalization for non-cardiac cause and no...

Unusually extensive and diverse case of infective endocarditis

Olga Możeńska, Sławomir Sypuła, Piotr Suwalski, Dariusz A. Kosior

Cor Vasa 2015, 57(1):e50-e53 | DOI: 10.1016/j.crvasa.2014.08.001  

We present the case of a 74-year-old man originally scheduled for planned surgical aortic valve replacement due to suspected infective endocarditis on a severely stenotic valve. Blood cultures revealed Enterococcus faecalis and Klebsiella pneumoniae (ESBL+). Logistic Euroscore was 9.11% and STS for isolated AV replacement (AVR) showed mortality risk 2.539% and 21.784% morbidity or mortality risk, respectively. AVR procedure was performed with mini-thoracotomy approach, ESP 100-21mm SJM prosthesis was implanted. On the 10th day following the procedure fever spikes with CRP and WBC elevation reoccurred and further course of the disease with all its capabilities...

Anomalous origin and course of left coronary artery-Cause of cardiac arrest in a young female athlete

Michaela Fischerová, Róbert Petr, Hana Hrabáková

Cor Vasa 2015, 57(1):e54-e58 | DOI: 10.1016/j.crvasa.2014.08.002  

Coronary artery anomalies represent a rare condition in the general population. Our case report describes a young female patient who survived sudden cardiac death caused by the left coronary artery arising atypically from the right coronary sinus.

Caught in the middle: Thrombus-in-transit through patent foramen ovale

Saroj Neupane, Naga V. A. Kommuri, Andrew M. Hauser

Cor Vasa 2015, 57(1):e59-e60 | DOI: 10.1016/j.crvasa.2014.10.002  

Návrh systému péče o vzácná onemocnění v kardiologii

Jana Popelová, Miloš Táborský, Pavel Jansa, Josef Kautzner, Jan Janoušek, Aleš Linhart, Jindřich Špinar

Cor Vasa 2015, 57(1):67-69  

Zápis ze schůze výboru ČKS konané 14. října 2014 v kanceláři ČKS v Brně

P. Widimský, T. Bracková, L. Klímová

Cor Vasa 2015, 57(1):73-74  

First Joint Meeting of the ESC Council on Hypertension and WG on Peripheral Circulation, Praha, 24.-25. 10. 2014

Cor Vasa 2015, 57(1):78-83  

VI. sjezd České společnosti kardiovaskulární chirurgie ČLS JEP a 17. Hejhalův den s mezinárodní účastí

Cor Vasa 2015, 57(1):84-132  

Antibiotická politika a prevence infekcí v nemocnici

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2015, 57(1):71  

Antikoagulační léčba u fibrilace síní

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2015, 57(1):72  

V roli pacienta se srdečním selháním aneb kasuistika trochu jinak

Lenka Nováková

Cor Vasa 2015, 57(1):75-77  

Za prof. MUDr. Jiřím Vítkem, CSc. (29. 3. 1935-19. 12. 2014)

Prof. MUDr. Josef Veselka, CSc.

Cor Vasa 2015, 57(1):70  

Editorial Board

Editorial board

Cor Vasa 2015, 57(1):i | DOI: 10.1016/S0010-8650(15)00005-3  

Výbor České kardiologické společnosti vyhlašuje výběrové řízení na místo šéfredaktora časopisu

Cor Vasa 2015, 57(1):13